Concepedia

Author

Katharina Bergerhoff

University College LondonORCID

Also Known As

Bergerhoff, Katharina, K. Bergerhoff, Katharina Bergerhoff, Katharina F. Bergerhoff

34

Publications

2.2K

Citations

10

H-Index

14

Concepts

All Affiliations

University College LondonInstitute of Cancer ResearchLondon CancerMemorial Sloan Kettering Cancer CenterRoyal Marsden Hospital
KB

About

Katharina Bergerhoff is an author at University College London specializing in tumor biology, tumor immunity, and immune regulation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

78

2

Cell Biology

1

1

78

3

Immunology

1

1

78

4

Autoimmunity

1

1

78

5

Immune Regulation

1

1

78

Katharina Bergerhoff

×

9

Publications

2.1K

Citations

9

H-Index

YearCitations

Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma

Tyler R. Simpson, Fubin Li, Welby Montalvo-Ortiz,

The Journal of Experimental Medicine

2013

1.4K

Regulatory T Cells Restrain Interleukin-2- and Blimp-1-Dependent Acquisition of Cytotoxic Function by CD4+ T Cells

Anna Śledzińska, Maria Vila de Mucha, Katharina Bergerhoff,

Immunity

2020

215

ATR Inhibition Potentiates the Radiation-induced Inflammatory Tumor Microenvironment

Magnus T. Dillon, Katharina Bergerhoff, Malin Pedersen,

Clinical Cancer Research

2019

200

TALEN-Mediated Inactivation of PD-1 in Tumor-Reactive Lymphocytes Promotes Intratumoral T-cell Persistence and Rejection of Established Tumors

Laurie Menger, Anna Śledzińska, Katharina Bergerhoff,

Cancer Research

2016

78

TALEN-mediated genetic inactivation of the glucocorticoid receptor in cytomegalovirus-specific T cells

Laurie Menger, Agnès Gouble, Maria A. V. Marzolini,

Blood

2015

58

Cellular Selectivity and Biological Impact of Cytotoxic Rhodium(III) and Iridium(III) Complexes Containing Methyl‐Substituted Phenanthroline Ligands

Y. Geldmacher, Igor Kitanović, Hamed Alborzinia,

ChemMedChem

2011

40

The PERK Inhibitor GSK2606414 Enhances Reovirus Infection in Head and Neck Squamous Cell Carcinoma via an ATF4-Dependent Mechanism

Martin McLaughlin, Malin Pedersen, Victoria Roulstone,

Molecular Therapy — Oncolytics

2020

34

Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer

Eva Crespo-Rodriguez, Katharina Bergerhoff, Galabina Bozhanova,

Journal for ImmunoTherapy of Cancer

2020

32

PD-1 Blockade Following Isolated Limb Perfusion with Vaccinia Virus Prevents Local and Distant Relapse of Soft-tissue Sarcoma

Henry Smith, David Mansfield, Victoria Roulstone,

Clinical Cancer Research

2019

28

Page 1